NCT01756417View on ClinicalTrials.gov

A Study to Investigate Whether Pharmacokinetic and Pharmacodynamic Interactions Exist Between Metformin and Canagliflozin (JNJ-28431754) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Healthy

Interventions

DRUG

Metformin

One 1,000 mg tablet of metformin taken orally (by mouth) on Day 1 and Day 8.

DRUG

Canagliflozin (JNJ-28431754)

Four 25 mg tablets of canagliflozin (JNJ-28431754) taken orally on Days 4 through 8.

Trial Locations (1)

Unknown

Neptune City

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT01756417 - A Study to Investigate Whether Pharmacokinetic and Pharmacodynamic Interactions Exist Between Metformin and Canagliflozin (JNJ-28431754) in Healthy Volunteers | Biotech Hunter | Biotech Hunter